Gastric bypass may change how your body absorbs painkillers
NCT ID NCT03476577
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study investigates how gastric bypass and sleeve gastrectomy—two common weight-loss surgeries—alter the way the body processes ibuprofen. Researchers will measure ibuprofen levels in the blood of 12 participants before and after surgery. The goal is to understand whether these procedures change drug absorption, which could affect pain relief and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ibuprofen
- What this could lead to
- If successful, this could help doctors adjust ibuprofen doses for people who have had weight-loss surgery, ensuring the drug works as intended.
- What could go wrong
- This is a small, early-stage study with only 12 participants, so results may not apply to everyone. It only looks at one drug, not all medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Olavs University Hospital
RECRUITINGTrondheim, Norway
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test